2022 annual financial data
MoonLake Immunotherapeutics 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -65,061,417 USD and net income was -64,506,051 USD.
Operating cash flow was -55,893,900 USD.
Get free MoonLake Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -65,061,417 USD
- Net income
- -64,506,051 USD
- Operating cash flow
- -55,893,900 USD